Bob's expertise and research focus lies within the field of parasite cell and molecular biology, as well as proteomics and population dynamics of malaria transmission. His research has an overall focus on discovery and characterisation of transmission-blocking vaccine candidates.
et al., 2019, Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis., Proc Natl Acad Sci U S A
et al., 2018, Polyamidoamine Nanoparticles for the Oral Administration of Antimalarial Drugs, Pharmaceutics, Vol:10, ISSN:1999-4923
et al., 2018, Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP, Npj Vaccines, Vol:3, ISSN:2059-0105
et al., 2018, A high throughput screen for next-generation leads targeting malaria parasite transmission, Nature Communications, Vol:9, ISSN:2041-1723
et al., 2017, ACCELERATING THE DISCOVERY OF TRANSMISSION-BLOCKING DRUGS: HT SCREENING WITH A NOVEL PLASMODIUM FALCIPARUM FUNCTIONAL GAMETOCYTE ASSAY, 65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH), AMER SOC TROP MED & HYGIENE, Pages:82-82, ISSN:0002-9637